Newsroom
Sorted by: Latest
-
Methylphenidate (CAS 113-45-1) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Methylphenidate (CAS 113-45-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Methylphenidate provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource fo...
-
Mianserin (CAS 24219-97-4) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Mianserin (CAS 24219-97-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Mianserin provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understa...
-
Aviation Capital Group Announces Closing of $1 Billion Senior Unsecured Notes
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aviation Capital Group LLC (“ACG”), a premier global full-service aircraft asset manager, announced today the closing of its sale of $1 billion of senior unsecured notes (the “Notes”). The sale consists of $600 million aggregate principal amount of 4.875% senior unsecured notes due in 2033 and $400 million aggregate principal amount of 4.250% senior unsecured notes due in 2029. The Notes are recourse only to ACG and are not guaranteed by ACG’s parent comp...
-
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
LONDON--(BUSINESS WIRE)--Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced that it has entered into a collaboration and licence agreement with Innolake Biopharm Co. Ltd (“Innolake”) to develop a clinical stage first-in-class antibody drug conjugate (ADC). Under the partnership, Ellipses gains rights to develop a B7H3 targeted ADC with an eribulin payload (ILB-3101) worldwide excluding greater China. ILB-3...
-
BRBR BREAKING STOCK ALERT: BFA Law Files a Securities Fraud Class Action Against BellRing Brands, Inc. after Inventory Issues lead to 19% Stock Drop -- Investors Notified to Contact the Firm
NEW YORK--(BUSINESS WIRE)--BFA Law Files a Securities Fraud Class Action Against BellRing Brands after Inventory Issues lead to 19% Stock Drop -- Investors Urged to Contact BFA...
-
Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...
-
Jeffrey Simon, David Greenstone Among Lawdragon’s Leading Lawyers for 2026
DALLAS--(BUSINESS WIRE)--Jeffrey Simon and David Greenstone, founding shareholders in the national trial firm Simon Greenstone Panatier, have been selected among the 2026 Lawdragon 500 Leading Lawyers in America, each earning repeat spots in the premier legal guide. Leading Lawyers honors are reserved for the top attorneys nationwide across all practice areas. The publication’s editors noted that this year’s honorees are “advocates who lead the way for clients, their communities, and their firm...
-
Publix Has Been Named on Fortune’s World’s Most Admired Companies List for 2026
LAKELAND, Fla.--(BUSINESS WIRE)--Publix has been recognized on Fortune’s World’s Most Admired Companies list. The company has been named on this list annually since 1996, marking the 31st consecutive year of earning this honor. This list acknowledges companies that make it a priority to commit to associates’ well-being, community engagement, sustainability efforts and being a great place to work, among other criteria. “At Publix, we pride ourselves on the culture we’ve built and continue to uph...
-
Weiss Asset Management LP UK Regulatory Announcement: Form 8.3
BOSTON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or v...
-
Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...